Disclosures for "Feasibility of Using Blood-based Biomarkers to Evaluate the Effectiveness of Individualized Neurodegenerative Disease Preventive Care"
-
Mr. Sisser has received personal compensation for serving as an employee of PAREF.
-
Dr. Niotis has nothing to disclose.
-
Dr. Seifan has received personal compensation in the range of $100,000-$499,999 for serving as a Chief Science Officer with HB Biotech.
-
Ms. Helfman has received personal compensation for serving as an employee of The Institute for Neurodegenerative Diseases of Florida.
-
Mr. Parthasarathy has nothing to disclose.
-
Mrs. Hristov has nothing to disclose.
-
Dr. Melendez-Herencia has nothing to disclose.
-
Miss Colvee has received personal compensation in the range of $500-$4,999 for serving as a Research Assistant with IND .
-
Ms. Lakis has received personal compensation for serving as an employee of Retain Health . Ms. Lakis has stock in Retain Health.
-
Dr. Janney has received personal compensation for serving as an employee of The Institute for Neurodegenerative Diseases (IND) Florida. Dr. Janney has received personal compensation for serving as an employee of HCW Biologics. Dr. Janney has stock in HCW Biologics.
-
Ms. Akiyoshi has nothing to disclose.
-
The institution of Dr. Huber has received research support from Bonner Forum Biomedizin. The institution of Dr. Huber has received research support from German Federal Ministry of Research. The institution of Dr. Huber has received research support from Demensförbundet. The institution of Dr. Huber has received research support from Adlerbertska forskningsstiftelsen.
-
Dr. Ashton has nothing to disclose.
-
Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Henrik Zetterberg has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Henrik Zetterberg has received personal compensation in the range of $0-$499 for serving as a Consultant for Acumen. Henrik Zetterberg has received personal compensation in the range of $0-$499 for serving as a Consultant for AlzPATH. Henrik Zetterberg has received personal compensation in the range of $0-$499 for serving as a Consultant for Annexon. Henrik Zetterberg has received personal compensation in the range of $0-$499 for serving as a Consultant for Apellis. Henrik Zetterberg has received personal compensation in the range of $0-$499 for serving as a Consultant for Fujirebio. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Siemens Healthineers. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Henrik Zetterberg has stock in Brain Biomarker Solutions.
-
Dr. Isaacson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Isaacson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. The institution of Dr. Isaacson has received research support from National Institutes of Health. The institution of Dr. Isaacson has received research support from Aces for Alzheimer's. The institution of Dr. Isaacson has received research support from BrainMind. Dr. Isaacson has received publishing royalties from a publication relating to health care.